Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Pituitary resistance to thyroid hormone is a rare, genetic thyroid disease, due to reduced pituitary gland responsiveness to thyroid hormone, characterized by mild to moderate hyperthyroidism in association with elevated circulating thyroid hormone levels, normal or elevated thyroid stimulating hormone, and no abnormalities of the pituitary gland on MRI. Patients present with diffuse large goiter, tachycardia, atrial fibrillation, weight loss and/or heat intolerance/perspiration, but no exophthalmos or anterior tibial mixedema.
Features include: Hyperthyroidism, Elevated circulating thyroid-stimulating hormone concentration, and Impaired sensitivity to thyroid hormone.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Hormones | 3 | Hyperthyroidism, Elevated circulating thyroid-stimulating hormone concentration, Impaired sensitivity to thyroid hormone |
THRB function has not been fully characterized.
Selective pituitary resistance to thyroid hormone is associated with mutations in the THRB gene on chromosome 3.
Genetic testing for THRB is available. Testing is considered confirmatory for diagnosis.
No clinical trials have been registered for selective pituitary resistance to thyroid hormone.
7 publications have been identified in PubMed for selective pituitary resistance to thyroid hormone. Research spans Review / Meta-Analysis (29%), Case Report / Case Series (29%), and Other (14%).
Zhang Y (2026). [PMID: 41176050](https://pubmed.ncbi.nlm.nih.gov/41176050/). *Clinica chimica acta; international journal of clinical chemistry*. [Review / Meta-Analysis]
Tzoraki M (2025). [PMID: 40760324](https://pubmed.ncbi.nlm.nih.gov/40760324/). *Hormones (Athens, Greece)*. [Other]
Ji D (2025). [PMID: 41446595](https://pubmed.ncbi.nlm.nih.gov/41446595/). *International journal of women's health*. [Epidemiology / Natural History]
Sinha RA (2025). [PMID: 39420154](https://pubmed.ncbi.nlm.nih.gov/39420154/). *Nature reviews. Gastroenterology & hepatology*. [Review / Meta-Analysis]
Liao W (2024). [PMID: 39091608](https://pubmed.ncbi.nlm.nih.gov/39091608/). *JCEM case reports*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 9:30 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Lab test results
1 |
Elevated circulating thyroid-stimulating hormone concentration |
Liu J (2024). [PMID: 39559298](https://pubmed.ncbi.nlm.nih.gov/39559298/). *International medical case reports journal*. [Case Report / Case Series]
Becker PC (2024). [PMID: 38801167](https://pubmed.ncbi.nlm.nih.gov/38801167/). *Thyroid : official journal of the American Thyroid Association*. [Basic Science / Preclinical]